Tremfya 100 MG/ML one-pressml
Ended Awarded Last action
- Contract number
- SPE2DR26FA1N0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,071
Award facts
- Contract value 100% obligated
- $56,070.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was awarded a delivery order by the Defense Logistics Agency (DLA) on January 6, 2026, for TREMFYA 100 mg/ml injections with a ceiling value of $56,070.57. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 7, 2026, and performance at the awardee's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's parent company, Cencora, Inc. (formerly trading as AmerisourceBergen), which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
This delivery order represents a task order execution under Cencora's comprehensive pharmaceutical supply vehicle that enables the company to provide medications and medical supplies to military healthcare programs globally. TREMFYA, a specialty pharmaceutical product used in dermatological treatment, exemplifies the type of brand-name medications within the company's extensive federal contract portfolio. The DLA Medical Supply Chain relies on such delivery orders to fulfill critical pharmaceutical needs across military treatment facilities and veterans' healthcare programs, with AmerisourceBergen serving as a key vendor in the government's pharmaceutical procurement ecosystem through competitive, full and open contracting processes.
Quick answers
Who was awarded contract SPE2DR26FA1N0?
SPE2DR26FA1N0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FA1N0 worth?
The government has obligated $56,071 on SPE2DR26FA1N0.
Is contract SPE2DR26FA1N0 an order under another contract?
Yes. SPE2DR26FA1N0 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA1N0 competed?
The extent of competition for SPE2DR26FA1N0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award